Top Abstract Purchase Related
Home
>
Node
>
Subnode

A case of male breast cancer with special reference to the hormonal environment during chemoendocrine therapy

Saito, K.; Hotta, T.; Kobayashi, S.; Miura, I.; Sakuma, S.; Shimozato, T.; Torii, T.; Iwase, H.; Satake, A.; Nishida, T.

Gan no Rinsho. Japan Journal of Cancer Clinics 31(13): 1727-1730

1985

ISSN/ISBN: 0021-4949
PMID: 3001383
Document Number: 247454
Chemoendocrine therapy was performed on a man with advanced breast cancer, and partial response was observed for 11 months. Estrogen receptor in cancer tissue was detected before and after the therapy. Progesterone receptor, however, was not detected after the treatment, whether it had been there or not prior to it. The serum estrone level was continuously high during the treatment, but the serum testosterone level was obviously decreased after that.

Document emailed within 1 workday
Secure & encrypted payments

Kiricuta, I.; Frenkel, Z.; Munteanu, S. 1975: Clinical and hormonal aspects in breast cancer with special reference to malignant evolutive push Archiv für Geschwulstforschung 45(5): 464-472
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Hortobagyi, G.N.; DiStefano, A.; Legha, S.S.; Buzdar, A.U.; Blumenschein, G.R. 1979: Hormonal therapy with tamoxifen in male breast cancer Cancer Treatment Reports 63(4): 539-541
Fersis, N.; Smyczek-Gargya, B.; Armeanu, S.; Gagulic, E.; Pantic, L.; Relakis, K.; Friedrich, M.; Wallwiener, D. 2004: Changes in vascular endothelial growth factor (VEGF) after chemoendocrine therapy in breast cancer European Journal of Gynaecological Oncology 25(1): 45-50
Wada, N.; Kobayashi, H.; Oka, S.; Ando, J.; Tamura, H. 2002: Combined chemoendocrine therapy using adriamycin, cyclophosphamide and high dose toremifene in patients with recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(11): 1935-1942
Nomura, Y.; Tashiro, H.; Hisamatsu, K.; Toi, M. 1988: Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 513-518
Kihara, M.; Kontani, K.; Yamauchi, A.; Yokomise, H. 2005: Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(5): 683-686
Yoshida, M.; Saji, S.; Takagi, H.; Takeuchi, S.; Tsuda, H.; Nimura, Y.; Mizumoto, R.; Miyazaki, I.; Kobayashi, S.; Noguchi, M. 1993: A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. the Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2325-2333
Sakuta, M.; Sumiyama, Y.; Okamoto, Y.; Noto, Y.; Naka, I.; Kiribayashi, T. 2002: A case of locally recurrent breast cancer in which phlebothrombosis of the right leg after hormonal therapy using a high dose of toremifene citrate Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(1): 115-118
Tamura, G.; Masuda, T.; Satodate, R.; Ishida, M.; Saitoh, K. 1988: Nuclear morphometry of cancer cells in stage III breast cancer with special reference to prognosis Gan no Rinsho. Japan Journal of Cancer Clinics 34(8): 977-980
Friedrich, M. 2000: Vitamin D and breast cancer: new approaches for hormonal therapy of breast cancer Clinical and Experimental Obstetrics and Gynecology 27(2): 77-82
Geppert, M.; Schmitt, W.G.; Hübener, K.H. 1984: Mammographic-histologic comparison in breast cancer with special reference to minimal cancers Rontgenpraxis; Zeitschrift für Radiologische Technik 37(7): 247-253
Berndt, G.; Eckel, H.; Notter, G.; St Stender, H. 1971: Effect of estrogen-gestagen combination therapy in advanced breast carcinoma with special reference to pulmonary metastases Strahlentherapie 141(5): 540-548
Abe, O.; Enomoto, K.; Ueda, M.; Kikuchi, K.; Fujiwara, K. 1991: Changes in future prospect in the management of breast cancer with special reference to BHENO- and GENO-type typic expression Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(9): 1395-1402
Kovács, A.; Klein, C. 1997: Madelung disease. A case report with special reference to therapy Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 68(3): 276-279
Murphy, B.; Muss, H.B. 1997: Hormonal therapy of breast cancer: state of the art Oncology 11(5 Suppl 4: 7-13
Ecker-Schlipf, B. 1994: Anti-hormonal therapy in breast cancer Medizinische Monatsschrift für Pharmazeuten 17(8): 247-250
This, P. 2005: Hormonal replacement therapy and breast cancer La Revue du Praticien 55(4): 377-382
Endo, Y.; Tanaka, K.; Tsuha, Y.; Fuse, C. 1972: Handling of the breast in breast feeding--with special reference to the effects of a breast pump Josanpu Zasshi 26(8): 16-20
Yonemura, Y.; Fujimura, T.; Takegawa, S.; Kamata, T.; Fushida, S.; Urade, M.; Miwa, K.; Miyazaki, I.; Nakajima, K.; Hisazumi, H. 1987: Multimodal therapy using hyperthermia for gastric cancer--with special reference to histological studies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(10): 2890-2894